Norges Bank’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Norges Bank's RNAM Position: Q2 2026 in Review
Norges Bank sold out of Avidity Biosciences (RNAM) in Q2 2026, closing a stake of 3,046,388 shares — an estimated $220M sold.
Norges Bank first reported a position in RNAM in Q4 2022 and held it in 8 quarters. The position peaked at $220M in Q4 2025. 0 funds tracked by Wall St. Rank hold RNAM as of Q2 2026.
- Norges Bank reported no remaining Avidity Biosciences position as of Q2 2026 after selling out during the quarter.
- Norges Bank sold 3,046,388 Avidity Biosciences shares in Q2 2026, an estimated $220M.
- Norges Bank first reported a position in Avidity Biosciences in Q4 2022 and held it in 8 quarters.
- Norges Bank's Avidity Biosciences position peaked at $220M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Avidity Biosciences as of Q2 2026.
Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.